Navigation Links
Do the Europeans turn ill sitting up so late?

An extensive EU-financed sleep research project is coordinated from FinlandIn spring 2005 a large European research and training network was establishedto investigate the causes and implications of poor sleep from the medical as well as from the social point of view. This EU-financed sleep research project, named"The biomedical and sociological effects of sleep restriction" will last for four yearsand is coordinated by Dr. Tarja Porkka-Heiskanen (Stenberg) MD, PhD, at theUniversity of Helsinki, Institute of Biomedicine.

The objective of this sleep restriction research is to characterize the physiological and behavioural effects of sleep loss and its social consequences. Sleep loss can be a consequence of sleep disorders, shift work, socio-economic constraints or voluntary restriction of sleep, due to life style. This can result in performance decrements, mood disorders, increased accident rates and considerable decrease in the quality of life.Sleep loss may also predispose individuals to conditions such as burn-out and cardiovascular diseases.

The EU has granted a 4,4 million Euro funding for this research project from the Marie Curie 6th Framework Program. In addition to Finland there are partners from UK, Belgium, Germany and Switzerland.

Many countries are involved in sleep research, but especially in the smaller countries it is very difficult to acquire the funding. This sleep restriction project brings together researchers from five countries, thus creating an efficient network where the special skills of each partner can be utilized.

The network will provide funding for 24 doctoral and post-doctoral researchers.A high level research training program is created in cooperation with the European universities, graduate schools and sleep research societies.

Dr. Tarja Porkka-Heiskanen (Stenberg) says:"We can choose relevant courses from the available universities, schools and research societies and provide the trainees with a versatile education. The main objective of the training is that the trainees acquire a wide international knowledge as well in basic research as in experimental and clinical research, and also in epidemiology and sociology. Simultaneously the trainees learn to work in an international research environment and can benefit from the large research network in the future."


'"/>

Source:University of Helsinki


Related biology news :

1. Biologists discover why 10% of Europeans are safe from HIV
2. First-time analysis reveals millions of Europeans left at risk from influenza
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), ... published by MarketsandMarkets, the market is expected to be worth USD 18.98 billion ... Continue Reading ... ...      (Logo: ...
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
(Date:3/20/2017)... 20, 2017 PMD Healthcare announces the release ... Wellness Management System (WMS), a remote, real-time lung health ... PMD Healthcare is a Medical Device, Digital Health, and ... to creating innovative solutions that empower people to improve ... focus, PMD developed the first ever personal spirometer, Spiro ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... March 27, 2017 Infectex Ltd., a Russian portfolio company of ... study of SQ109 added to the standard drug therapy regimen in patients with multidrug-resistant ... Sequella, Inc. ( USA ) and the US National Institutes of Health. ... ... Biotech Venture Fund Logo ...
(Date:3/27/2017)... ... 2017 , ... A research team led by Mai Lam, ... Video Journal, the world’s first peer-reviewed scientific video journal. The article demonstrates a ... disease (CAD). Lam is an assistant professor at the Department of Biomedical Engineering ...
(Date:3/24/2017)... ROCKVILLE, Md. , March 24, 2017 ... Biotech Venture Fund (MBVF), today announced positive results of ... the standard drug therapy regimen in patients with multidrug-resistant ... drug discovered by scientists at Sequella, Inc. ( ... Health. A total of 140 patients ...
(Date:3/24/2017)... Mass. , March 24, 2017 Agenus ... of immune checkpoint antibodies and cancer vaccines, today announced ... The 7 th  Annual William Blair and Maidstone Life ... Space Alexandria Center in New York, NY ... March 29 at 9:40 am: Robert ...
Breaking Biology Technology: